Announcements Trials
Browse Landscape

Phase

Phase 1 11Phase 3 3Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT06712381 2024-12-02

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Skin Laser & Surgery Specialists

Phase 1/2 Completed
60 enrolled
Dermatologic

Keratosis, Actinic

NCT00988455 2009-10-02

Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up

Shahid Beheshti University of Medical Sciences

Phase 1/2 Completed
28 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡